EUVIMEDEUVIMED entdecken
Crossref

Association Between Low Serum microRNA ‐26a Levels and Major Adverse Cardiovascular or Cerebrovascular Events in Patients Undergoing Hemodialysis

Yuanfang Li, Ke Wu, Yuezhen Zhang, Xianfang Wang iD

Hemodialysis International · 2026

DOI: 10.1111/hdi.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hemodialysis International, 2026. Verfasst von Yuanfang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Gaoping District People's Hospital of Nanchong, Nanchong, Sichuan, China. Hauptthemen laut MEDLINE: MicroRNAs, Renal Dialysis, Cardiovascular Diseases, Kidney Failure, Chronic. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Nanchong Municipal Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Patients with end‐stage kidney disease face an extremely high risk of major adverse cardiovascular and cerebrovascular events. This study investigated the role of microRNA‐26a in patients with end‐stage kidney disease who have been receiving long‐term hemodialysis.

Methods

Blood samples were collected from patients with chronic kidney disease stages I–III and from those with end‐stage kidney disease. Basic clinical information was recorded for all participants. Serum expression of microRNA‐26a was measured using real‐time quantitative polymerase chain reaction. Pearson correlation analysis was used to examine the relationships between microRNA‐26a levels and clinical indicators, including serum albumin, estimated glomerular filtration rate, high‐sensitivity C‐reactive protein, serum creatinine, and blood urea nitrogen. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed to evaluate the association of microRNA‐26a with disease progression and the occurrence of major adverse cardiovascular and cerebrovascular events.

Results

Serum microRNA‐26a levels were significantly lower in patients with end‐stage kidney disease compared with those with earlier‐stage chronic kidney disease. MicroRNA‐26a expression showed a positive correlation with serum albumin and estimated glomerular filtration rate, and negative correlations with high‐sensitivity C‐reactive protein, serum creatinine, and blood urea nitrogen. ROC curve analysis demonstrated that serum microRNA‐26a levels had good diagnostic value for identifying end‐stage kidney disease (area under the curve = 0.842). During follow‐up, the cumulative incidence of major adverse cardiovascular and cerebrovascular events was 14% at 12 months, 22% at 24 months, and 34% at 36 months. MicroRNA‐26a expression was significantly lower in patients who experienced these events. Both univariate and multivariate logistic regression analyses identified higher serum microRNA‐26a levels as an independent protective factor against major adverse cardiovascular and cerebrovascular events in patients with end‐stage kidney disease.

Conclusion

In patients with end‐stage kidney disease receiving long‐term hemodialysis, microRNA‐26a levels are associated with disease severity and the risk of major adverse cardiovascular and cerebrovascular events. Lower miR‐26a expression may serve as a potential biomarker for disease monitoring and risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRenal DialysisCardiovascular DiseasesKidney Failure, ChronicCerebrovascular DisordersHumansFemaleMaleMiddle AgedAged

Stichwörter der Autor:innen

CKDESKDMACCEhemodialysismiR‐26a

Substanzen

MicroRNAsMIRN26 microRNA, human

Autor:innen und Institutionen

  • Department of Nephrology, Gaoping District People's Hospital of Nanchong, Nanchong, Sichuan, China.
  • Nephrology Department, The Eighth Hospital of Wuhan (Wuhan Anorectal Hospital), Wuhan, China.
  • Rheumatology and Immunology Department, Haemodialysis Centre, Zhejiang Provincial People's Hospital Southeast Campus, Zhejiang, China.
  • Hospital Infection Control Office, Hubei Provincial Hospital of TCM, Wuhan, Hubei, China.

ORCID-Profile: Xianfang Wang

Förderung

  • Nanchong Municipal Science and Technology Program

Zitieren

APA

Li, Y., Wu, K., Zhang, Y., & Wang, X. (2026). Association Between Low Serum microRNA ‐26a Levels and Major Adverse Cardiovascular or Cerebrovascular Events in Patients Undergoing Hemodialysis. Hemodialysis International. https://doi.org/10.1111/hdi.70086

Vancouver

Li Y, Wu K, Zhang Y, Wang X. Association Between Low Serum microRNA ‐26a Levels and Major Adverse Cardiovascular or Cerebrovascular Events in Patients Undergoing Hemodialysis. Hemodialysis International. 2026. doi:10.1111/hdi.70086

BibTeX
@article{Li2026,
  author = {Li, Yuanfang and Wu, Ke and Zhang, Yuezhen and Wang, Xianfang},
  title = {Association Between Low Serum microRNA ‐26a Levels and Major Adverse Cardiovascular or Cerebrovascular Events in Patients Undergoing Hemodialysis},
  journal = {Hemodialysis International},
  year = {2026},
  doi = {10.1111/hdi.70086}
}
Kostenlos starten →